DePuy Synthes

DePuy Synthes provides one of the most comprehensive orthopaedics portfolios in the world that helps heal and restore movement for the millions of patients we serve. Our solutions—including joint reconstruction, trauma, extremities, craniomaxillofacial, spinal surgery, and sports medicine—alongside the VELYS Digital Surgery portfolio, are designed to support improved patient care and deliver clinical and economic value to healthcare systems worldwide. Building on a legacy of product innovation and industry firsts, we continue to shape the orthopaedic landscape through advancements in medical technologies and digital surgery across the continuum of care to Keep People Moving today and tomorrow.

On 14 October 2025, Johnson & Johnson announced plans to separate its Orthopaedics business into a standalone company operating as DePuy Synthes. The planned separation is targeted for completion in 18–24 months, subject to required conditions.